Researchers aim to spark action to address rising homelessness among older people
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Apr-2025 15:08 ET (22-Apr-2025 19:08 GMT/UTC)
Agricultural economists with the Arkansas Agricultural Experiment Station conducted a survey with Mexican consumers to get an idea of what premiums the consumers would be willing to pay for non-genetically modified corn in light of a 2020 presidential decree calling for the nation to phase out genetically modified maize, or corn. Mexico is the second-largest importer of U.S. corn after China. In terms of cash farm receipts, corn is one of Arkansas’ top commodities and worth about $652 million and Arkansas is ranked at No. 15 in corn for grain production. Brandon McFadden, a professor of agricultural economics and agribusiness and the Tyson Endowed Chair in Food Policy Economics, showed that more than half of those surveyed didn’t know about the Mexican government decree and many dropped support once they saw how much prices would go up. He also pointed out a fully implemented ban could impact lower-income Mexican consumers more since they spend a higher proportion of their money on food.
A survey of patients receiving gender affirming care shows that commercial insurance pays for most of their treatments, they receive less care in the South than other parts of the U.S. and they deal with disproportionate levels of housing insecurity and trauma compared to others, according to a new study by researchers at the Colorado School of Public Health and the University of Colorado Anschutz Medical Campus.
The study, using data provided by Kythera Labs, a healthcare clearinghouse, examined millions of insurance claims by patients undergoing gender affirming care (GA) and those not. It also looked at social determinants of healthcare (SDOH), non-medical factors which affect a person’s quality of life.
The study was published today in the Journal of General Internal Medicine.
It showed that commercial insurance covered 72.8% of GA claims followed by Medicaid at 17.2 %, other insurance at 6.6% and Medicare at 3.5%. GA patients incurred more claims across all insurance and age groups, about 87% more overall.